A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy (Q33345142)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy |
scientific article |
Statements
1 reference
A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy (English)
1 reference
J Sehouli
1 reference
D Stengel
1 reference
G Oskay
1 reference
O Camara
1 reference
H-J Hindenburg
1 reference
P Klare
1 reference
J Blohmer
1 reference
G Heinrich
1 reference
D Elling
1 reference
P Ledwon
1 reference
W Lichtenegger
1 reference
NOGGO study group
1 reference
1 November 2002
1 reference
1 reference
Identifiers
1 reference